Obesity Cancer

Cancer cases linked with obesity, previously observed as rising among the youth, could also be increasing in both young and older adults worldwide, according to a global analysis. Researchers from The Institute of Cancer Research and Imperial College London cautioned that new studies focusing solely on younger adults for rise in cancer cases should be carefully considered. The study, published in the journal Annals of Internal Medicine, which examined annual cancer incidence from 2003 to 2017 found that five obesity-related cancers -- thyroid, breast, kidney, endometrial, and blood (leukaemia) -- have risen in both adults aged 2049 and those 50 and older. All the five cancers are related to obesity, the team said. The data from 42 countries across Asia, Europe, Africa, North and South America, and Australasia drawn from the International Agency for Research on Cancer's 'GLOBOCAN' database was analysed. Rates of cancer incidence were found to have increased among younger adults in

New obesity drugs such as Novo Nordisk A/S's Wegovy and Eli Lilly & Co.'s Zepbound could be an $80 billion market by 2030

The new research integrates animal studies, clinical trials, and public health data to help explain rising cancer rates

These cells were found in greater number in obese prostate cancer and obese breast cancer patients